期刊文献+
共找到911篇文章
< 1 2 46 >
每页显示 20 50 100
Prophylactic Bactericidal Orthopedic Implants – Animal Testing Study
1
作者 Richard A. Wysk Wayne J. Sebastianelli +9 位作者 Rohan A. Shirwaiker Gregory M. Bailey Charumani Charumani Mary Kennett Amy Kaucher Rachel Abrahams Thomas A. Fuller Patricia Royer Robert C. Voigt Paul H. Cohen 《Journal of Biomedical Science and Engineering》 2010年第9期917-926,共10页
This paper summarizes preliminary rat studies aimed at identifying the effectiveness of using electrically stimulated silver as a bactericidal agent for indwelling residual hardware devices (RHD). A variety of bacteri... This paper summarizes preliminary rat studies aimed at identifying the effectiveness of using electrically stimulated silver as a bactericidal agent for indwelling residual hardware devices (RHD). A variety of bactericidal indwelling devices were designed, fabricated and surgically inserted into the medullary cavity of live rats. The rats were inoculated with Staphylococcus aureus to try and induce osteomyelitis. A total of 37 surgeries were performed by implanting the rats with both control and potentially bactericidal devices. As surgical procedures and devices were improved, it appeared that the implants produced antibiotic effects in the animals. All of the control animals and all of the animals where the device failed tested positive for Staphylococcus aureus growth. Of the rats with operational bactericidal devices (those that survived the surgery and incubation period), half tested negative for Staphylococcus aureus. The device designs are discussed in this paper along with the test procedures, operating practices and results. A statistical analysis of the results, which shows a very high confidence level in the effectiveness of electrically stimulated silver as a bactericidal agent/antibiotic, is also presented. 展开更多
关键词 Antibacterial ANTIMICROBIAL BACTERICIDAL SILVER Ionic SILVER Residual Hardware Devices (RHD) animal testing
下载PDF
Current Status of Global Ban on Cosmetic Tests on Animals
2
作者 Yifan Jiang 《China Detergent & Cosmetics》 2016年第1期33-39,共7页
The article reviewed the cosmetic animal testing ban globally, with focusing on EU, United Kingdom, Korea, the United States, Russia, Australia, Canada and others total 15 regions and countries. The article also brief... The article reviewed the cosmetic animal testing ban globally, with focusing on EU, United Kingdom, Korea, the United States, Russia, Australia, Canada and others total 15 regions and countries. The article also briefed the developments of the alternatives of animal testing in the world, and the cosmetic animal testing regulation in China as well. The article suggested China to adopt the alternatives which have been validated based on the development of technology, gradually ban animal testing for cosmetics. 展开更多
关键词 globe COSMETICS animal testing BAN alternatives
下载PDF
ChinaRegulatory Updates of Animal Testing in China and Other Courtries
3
作者 Chen Ye Wang Chris 《China Detergent & Cosmetics》 2021年第2期24-30,共7页
YeAnimal testing for the sake of cosmetic safety has always been a very controversial topic since it’s often viewed as cruel due to its harm,or outright death,of the animals subjected to them.In the early years,anima... YeAnimal testing for the sake of cosmetic safety has always been a very controversial topic since it’s often viewed as cruel due to its harm,or outright death,of the animals subjected to them.In the early years,animal testing was adopted to assess product safety and allergenicity during the R&D of cosmetics and daily chemical products.Since then,we have seen significant technological advancements to the extent that people argue that animal tests have become largely redundant.As a response,cruelty-free advocates have made huge headway in lobbying governments to ban animal testing.In this report,I will look at those major advancements in the global push towards a global ban on animal testing. 展开更多
关键词 testING animal REDUNDANT
下载PDF
Development of Alternative to Animal Testing on Cosmetics by Middle-out Strategy
4
作者 Shujun Cheng Yu Chen +3 位作者 Yihui Ke Xiaoting Qu Yao Qin Jiating Xu 《China Detergent & Cosmetics》 2016年第4期32-36,共5页
The discussion on cosmetic animal testing ban started since 1990s, with the fnally implementation of full animal testing ban in both research and marketing in EU and Israel in 2013. Now it has been fully or partially ... The discussion on cosmetic animal testing ban started since 1990s, with the fnally implementation of full animal testing ban in both research and marketing in EU and Israel in 2013. Now it has been fully or partially banned by law in 33 countries or regions, with more and more countries lining up to do the same. Beyond animal welfare consideration, the need of mutual acceptance of data (MAD) and harmonization of global market have made non-animal testing an irresistible general trend for worldwide countries to made regulation and policy. Recently, China is in critical crossroad to shift the toxicity paradigm and explore a proper strategy to promote the development of cosmetic non-animal testing. 3R theory has been frstly introduced in Chinese legislation in 2006 that is an important step forward to seriously thinking of animal test. In the following 10 years, the alternative technology in China has been developed dramatically with the implementation of relevant legislations, holding various theoretical and hands-on training, exploration work on methods validation, adoption of internationally recognized methods, propagation of alternative standards and in-depth investigation in in vitro bioscience. The ultimate goal of alternative technology is the regulatory application, thus demands infrastructure constructing, technology capability building and national standard forming. However, concrete works should be carefully planned to facilitate the technology transformation and standardization. This paper will give a retrospective review on the progress in recent years and put forward a middle-out strategy to promote the development of cosmetics alternative in China. 展开更多
关键词 in vitro alternative methods animal testing COSMETICS
下载PDF
CNAL Held International Proficiency Testing Workshop on Animal Quarantine
5
《China Standardization》 2004年第5期32-32,共1页
关键词 CNAL Held International Proficiency testing Workshop on animal Quarantine
下载PDF
Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis 被引量:53
6
作者 Hong Lei Weng Wei Min Cai Rong Hua Liu Institute of Infectious Diseases, First Affiliated Hospital. Medical School. Zhejiang University, Hangzhou 310003, Zhejiang Province. China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第1期42-48,共7页
AIM: To evaluate the antifibrotic effect of different doses of recombinant human Gamma-Interferon (IFN-gamma) in two rat models of hepatic fibrosis, and to observe its effect on moderate chronic hepatitis B virus fibr... AIM: To evaluate the antifibrotic effect of different doses of recombinant human Gamma-Interferon (IFN-gamma) in two rat models of hepatic fibrosis, and to observe its effect on moderate chronic hepatitis B virus fibrosis. METHODS: Hepatic fibrosis was successfully induced in 150 and 196 rats by subcutaneous injection of carbon tetrachloride (CCl4) and intraperitoneal injection of dimethylnitrosamine (DMN), respectively. Each of the two model groups was divided into: (1) fibrotic model group; (2) colchicine treatment group (0.1 mg/kg/day, gastrogavage for 8 weeks); (3) high-dose IFN-gamma group (15 MU/kg per day, i.m. for 8 weeks); (4) medium-dose IFN-gamma group (5 MU/kg daily, i.m. for 8 weeks); and (5) Y low-dose IFN-gamma group (1.67 MU/kg daily, i.m. for 8 weeks). Another group of 10 rats without any treatment was used as normal controls. At the end of the experiment, semi-quantitative histopathological scores of inflammation and fibrosis, liver alpha smooth muscle actin (alpha-SMA) expression level, liver hydroxyl proline content and serum hyaluronic acid levels were compared. And 47 medium chronic hepatitis B viral fibrosis patients were studied. They were given IFN-gamma treatment, 100 MU/day i.m. for the first three months and 100 MU qod i.m. for the next six months. Semi-quantitative pathological scores of inflammation and fibrosis and serum hepatic fibrosis indices were compared within the 9 months. RESULTS: In animal experiment, the pathological fibrosis scores and liver hydroxyl proline content were found to be significantly lower in rats treated with different doses of IFN-gamma as compared with rats in fibrotic model group induced by either CCl4 or DMN, in a dose-dependent manner. For CCl4-induced model, pathological fibrosis scores in high, medium and low doses IFN-gamma groups were 5.10 +/- 2.88, 7.70 +/- 3.53 and 8.00 +/- 3.30, respectively, but the score was 14.60 +/- 7.82 in fibrotic model group. Hydroxyl proline contents were 2.83 +/- 1.18, 3.59 +/- 1.22 and 4.80 +/- 1.62, in the three IFN-gamma groups, and 10.01 +/- 3.23 in fibrotic model group. The difference was statistically significant (P【0.01). Similar results were found in DMN-induced model. Pathological fibrosis scores were 6.30 +/- 0.48, 8.10 +/- 2.72 and 8.30 +/- 2.58, in high, medium and low doses IFN-gamma groups, and 12.60 +/- 3.57 in fibrotic model group. Hydroxyl proline contents were 2.72 +/- 0.58, 3.14 +/- 0.71 and 3.62 +/- 1.02, in the three IFN-gamma groups, and 12.79 +/- 1.54 in fibrotic model group. The difference was statistically significant (P【0.01).Serum hepatic fibrosis indices decreased significantly in the 47 patients after IFN-gamma treatment (HA: 433.38 +/- 373.00 vs 281.57 +/- 220.48; LN: 161.22 +/- 41.02 vs 146 +/- 35 +/- 44. 67; PC III: 192.59 +/- 89.95 vs 156.98 +/- 49.22; C-I: 156.30 +/- 44.01 vs 139.14 +/- 34.47) and the differences between the four indices were significant (P 【0.05). Thirty-three patients received two liver biopsies, one before and one after IFN-gamma treatment. In thirty of 33 patients IFN-gamma had better effects according to semi-quantitative pathological scores (8.40 +/- 5.83 vs 5.30 +/- 4.05, P【0.05). CONCLUSION: All the three doses of IFN-gamma are effective in treating rat liver fibrosis induced by either CCl4 or DMN, the higher the dose, the better the effect. And IFN-gamma is effective for patients with moderate chronic hepatitis B viral fibrosis. 展开更多
关键词 animals Antineoplastic Agents dosage Biopsy Carbon Tetrachloride DIMETHYLNITROSAMINE Disease Models animal Female Hepatitis B Chronic Humans Hyaluronic Acid HYDROXYPROLINE Interferon-gamma Recombinant Liver Liver Cirrhosis Liver Function tests Male RATS Rats Sprague-Dawley
下载PDF
Biocompatibility of vascular stents manufactured using metal injection molding in animal experiments 被引量:3
7
作者 Chang SHU Hao HE +5 位作者 Bo-wen FAN Jie-hua LI Tun WANG Dong-yang LI Yi-min LI Hao HE 《Transactions of Nonferrous Metals Society of China》 SCIE EI CAS CSCD 2022年第2期569-580,共12页
This study aimed to evaluate the feasibility and safety of a novel stent manufactured by metal injection molding(MIM)in clinical practice through animal experiments.Vessel stents were prepared using powder injection m... This study aimed to evaluate the feasibility and safety of a novel stent manufactured by metal injection molding(MIM)in clinical practice through animal experiments.Vessel stents were prepared using powder injection molding technology to considerably improve material utilization.The influence of MIM carbon impurity variation on the mechanical properties and corrosion resistance of 316L stainless steel was studied.In vitro cytotoxicity and animal transplantation tests were also carried out to evaluate the safety of MIM stents.The results showed that the performance of 316L stainless steel was very sensitive to the carbon content.Carbon fluctuations should be precisely controlled during MIM.All MIM stents were successfully implanted into the aortas of the dogs,and the MIM 316L stents had no significant cytotoxicity.The novel intravascular stent manufactured using MIM can maintain a stable form and structure with fast endothelialization of the luminal surface of the stent and ensure long-term patency in an animal model.The novel intravascular stent manufactured using MIM demonstrates favorable structural,physical,and chemical stability,as well as biocompatibility,offering promising application in clinical practice. 展开更多
关键词 vascular stent metal injection molding cytotoxicity test animal experiment BIOCOMPATIBILITY
下载PDF
Recent advances in anxiety disorders:Focus on animal models and pathological mechanisms 被引量:2
8
作者 Hongqing Zhao Mi Zhou +2 位作者 Yang Liu Jiaqi Jiang Yuhong Wang 《Animal Models and Experimental Medicine》 CAS CSCD 2023年第6期559-572,共14页
Anxiety disorders have become one of the most severe psychiatric disorders,and the incidence is increasing every year.They impose an extraordinary personal and socioeconomic burden.Anxiety disorders are influenced by ... Anxiety disorders have become one of the most severe psychiatric disorders,and the incidence is increasing every year.They impose an extraordinary personal and socioeconomic burden.Anxiety disorders are influenced by multiple complex and interacting genetic,psychological,social,and environmental factors,which contribute to disruption or imbalance in homeostasis and eventually cause pathologic anxiety.The selection of a suitable animal model is important for the exploration of disease etiology and pathophysiology,and the development of new drugs.Therefore,a more comprehensive understanding of the advantages and limitations of existing animal models of anxiety disorders is helpful to further study the underlying pathological mechanisms of the disease.This review summarizes animal models and the pathogenesis of anxiety disorders,and discusses the current research status to provide insights for further study of anxiety disorders. 展开更多
关键词 animal models anxiety disorders behavioral tests mental diseases PATHOGENESIS
下载PDF
Serological Survey of Zika Virus in Humans and Animals in Dejiang Prefecture, Guizhou Province,China 被引量:1
9
作者 LI Fan ZHOU Jing Zhu +12 位作者 ZHOU Lei FU Shi Hong TIAN Zhen Zao WANG Qi SHAO Nan LI Dan HE Ying LEI Wen Wen TANG Guang Peng LIANG Guo Dong WANG Ding Ming ZHANG Yan Ping WANG Huan Yu 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2019年第12期875-880,共6页
Objective The current outbreak of Zika virus(ZIKV)poses a severe threat to human health.Two ZIKV strains were isolated from mosquitoes collected from the Dejiang prefecture in China in 2016,which was the first isolati... Objective The current outbreak of Zika virus(ZIKV)poses a severe threat to human health.Two ZIKV strains were isolated from mosquitoes collected from the Dejiang prefecture in China in 2016,which was the first isolation of ZIKV in nature in China.Methods In this study,serum samples were collected from 366 healthy individuals and 104 animals from Dejiang prefecture in 2017,and the plaque reduction neutralization test(PRNT)was used to evaluate the seroprevalence of ZIKV.Results None of the 366 residents from whom the samples were collected were seropositive for ZIKV.None of the 11 pigs from whom the samples were collected were seropositive for ZIKV,while 1 of 63(1.59%)chickens and 2 of 30(6.67%)sheep were seropositive for ZIKV.Conclusions The extremely low seropositivity rate of ZIKV antibodies in animals in the Dejiang prefecture,Guizhou province in this study indicates that ZIKV can infect animals;however,there is a low risk of ZIKV circulating in the local population. 展开更多
关键词 Zika Virus Serological survey Humans animalS China Plague reduction neutralization test
下载PDF
Pilot-Scale Production of Lyophilized Inactivated Rabies Vaccine Candidate in Vero Cells under Fully Animal Component-Free Conditions Using Microcarrier Technology and Laboratory Animal Trials
10
作者 Engin Alp Onen Srinivas Bezawada 《Journal of Biomedical Science and Engineering》 2022年第6期157-178,共22页
The upstream process was carried out in an animal component-free medium on Cytodex 1 microcarriers. Recombinant trypsin is a non-animal derived protease used as an alternative to animal-derived trypsin. To inactivate ... The upstream process was carried out in an animal component-free medium on Cytodex 1 microcarriers. Recombinant trypsin is a non-animal derived protease used as an alternative to animal-derived trypsin. To inactivate recombinant trypsin, a soybean trypsin inhibitor (STI) should be added to the medium. A protocol was first tested in T-flasks and then passaged to 500 mL and 3 L spinner flasks. Cell detachment was completed in 10 - 12 min, and 0.4 g/L STI was added to a 3L spinner, and cells were transferred into a 30 L stirred tank bioreactor. On day 5, the cell density had reached its maximum (around 1.8 × 106 cells/mL). At an MOI of 0.3 with serum-free medium conditions, cell infection yielded a maximal rabies virus titer of 1.82 × 10<sup>7</sup> FFU/mL at 5 days. All cell culture conditions and virus growth kinetics in serum-free media were investigated. In conclusion, Vero cells were grown on Cytodex 1 with serum-free media and a high amount of rabies virus was obtained. A mouse challenge was used to determine the immune response to an inactivated rabies virus vaccine candidate. Also, we evaluated inactive rabies vaccine candidate safety, and immunogenicity in mice, sheep, horses, and cattle. We found that no horses, sheep, or cattle who were given vaccine IM at 3.2 IU/dose exhibited any clinical sign of disease and all developed high VNA titers (up to 10.03 IU/mL) by 3 - 4 WPI. After the accelerated stability studies, the lyophilized inactivated rabies vaccine candidate showed enough antigenic potency (2.6 IU/mL) in the mouse challenge test. Also, 18-month long-term stability studies showed enough immune response (1.93 IU/mL) on day 14. The activity of the vaccine candidate showed a good immune response and safety criteria that meet WHO requirements. This is the first pilot-scale mammalian cell-based viral rabies vaccine production study in Türkiye that used microcarriers. 展开更多
关键词 LYSSAVIRUS RABIES VIROLOGY Inactivated Vaccine Potency test MICROCARRIERS TEM Analysis Vero Cell Culture Serum-Free Medium Non-animal Derived Recombinant Trypsin Preclinical Trials
下载PDF
神经行为学实验Narrow-Alley Test及Corner Test改良:Narrow-Alley Corner Test 被引量:9
11
作者 陈绍春 潘伟生 +3 位作者 李明 路钢 冯忠堂 李圆圆 《中国实验动物学报》 CAS CSCD 2007年第6期406-409,I0002,共5页
目的改良传统的Narrow-alley Test及Corner Test,增强实验的可操作性和结果的可靠性。方法用Narrow-alley Test、Corner Test及改良后的Narrow-alley Corner Test检测三组SD大鼠:脑出血+GCSF治疗组;脑出血+生理盐水安慰治疗组;正常对照... 目的改良传统的Narrow-alley Test及Corner Test,增强实验的可操作性和结果的可靠性。方法用Narrow-alley Test、Corner Test及改良后的Narrow-alley Corner Test检测三组SD大鼠:脑出血+GCSF治疗组;脑出血+生理盐水安慰治疗组;正常对照组。结果(1)与Narrow-alley Test及Corner Test结果一致,正常大鼠在Narrow-alleyCorner Test实验装置中向左、向右"站立转身"的几率接近,而脑损伤大鼠则趋向沿损伤同侧作"站立转身"。(2)Narrow-alley Corner Test不须反复刺激大鼠,减少了人在实验现场对动物活动的影响,增强了实验的可操作性和结果的可信度。结论Narrow-alley Corner Test是一种可操作性强、结果可靠的神经行为学检测方法。 展开更多
关键词 神经行为学 动物实验 改良
下载PDF
Role of the^(13)C-methacetin breath test in the assessment of acute liver injury in a rat model 被引量:3
12
作者 Dong Zhu Hui Zhang +3 位作者 Jing-Yi Mao Hong-Yan Wang Xin Li You-Qing Xu 《World Journal of Gastroenterology》 SCIE CAS 2014年第32期11305-11312,共8页
AIM: To evaluate the role of the 13C-methacetin breath test(13C-MBT) in the assessment of acute liver injury in a rat model.METHODS: Acute liver injury in rats was induced by a single intraperitoneal injection of D-ga... AIM: To evaluate the role of the 13C-methacetin breath test(13C-MBT) in the assessment of acute liver injury in a rat model.METHODS: Acute liver injury in rats was induced by a single intraperitoneal injection of D-galactosamine(D-GalN). Forty-eight male Sprague-Dawley rats were randomly assigned to a control group(n = 8) and five model groups(each n = 8), and acute liver injury was assessed at different time points(6, 12, 24, 48 and 72 h) after D-GalN injection. The 13C-MBT, biochemical tests, 15-min retention rate of indocyanine green(ICGR15), and liver biopsy were performed and compared between the control and model groups. Correlations between parameters of the 13C-MBT(Tmax, MVmax, CUM120 and DOBmax), biochemical tests, ICGR15 and liver necrosis score were also analyzed using Spearman'scorrelation analysis.RESULTS: Tmax, MVmax, CUM120 and DOBmax, as well as most of the traditional methods, correlated with the liver necrosis score(r = 0.493, P < 0.05; r =-0.731, P < 0.01; r =-0.618, P < 0.01; r =-0.592, P < 0.01, respectively). MVmax, CUM120 and DOBmax rapidly decreased and were lower than those in the controls as early as 6 h after D-GalN injection(3.84 ± 0.84 vs 5.06 ± 0.78, P < 0.01; 3.35 ± 0.72 vs 4.21 ± 1.44, P < 0.05; 52.3 ± 20.58 vs 75.1 ± 9.57, P < 0.05, respectively) and reached the lowest point 24 h after D-GalN injection. MVmax, CUM120 and DOBmax returned to normal levels 72 h after D-GalN injection and preceded most of the traditional methods, including liver biopsy.CONCLUSION: The 13C-MBT is a sensitive tool for the timely detection of acute liver injury and early prediction of recovery in a rat model. Further clinical studies are warranted to validate its role in patients with acute liver injury. 展开更多
关键词 13C-methacetin breath test Acute liver injury Liver function animal model
下载PDF
完善实验动物废物处置质量管理体系的思考:以中国食品药品检定研究院为例
13
作者 马丽颖 赵明海 +2 位作者 梁春南 岳秉飞 王洪 《实验动物与比较医学》 CAS 2024年第2期214-219,共6页
科技发展是推动人类社会前进的巨大动力,而实验动物资源是生命科学、医药等领域科技发展的条件保障。但在开展医药研发、检验检测等实验过程中,使用实验动物产生的废物也为城市管理带来了新的考验。废物的分类、回收、有效利用和生物安... 科技发展是推动人类社会前进的巨大动力,而实验动物资源是生命科学、医药等领域科技发展的条件保障。但在开展医药研发、检验检测等实验过程中,使用实验动物产生的废物也为城市管理带来了新的考验。废物的分类、回收、有效利用和生物安全危害等问题接踵而至,对法规、标准、规范等的制定提出了与时俱进的要求。质量管理体系建设是检验检测机构管理的地基和框架,具备较强的操作性和检查性,可以不断提升管理水平,加强基础管理的稳定性。随着各层级新的管理办法出台,很多单位现行的质量管理体系内关于实验动物废物管理的相关内容欠妥,存在未明确非医疗机构实验动物废物处置流程、实验动物废物分类不准确、不同分类的废物未能按照不同方式处置等问题。本文针对目前存在的问题,梳理了中国食品药品检定研究院质量管理体系需要增加或者删改的流程,并制订了现行有效的标准作业流程,在如何加强监督管理方面提出了切实可行的措施,并开创性地把6S管理内容纳入质量管理体系中。因此,针对实验动物废物的管理应从完善质量管理体系的角度出发,从源头做好废物分类和管理,有效控制生物危害,最大限度地减少环境污染,为可持续发展创造条件。 展开更多
关键词 废物 质量管理 实验动物 检验检测机构
下载PDF
2013-2021年实验动物质量检测能力验证情况
14
作者 王洪 魏杰 +5 位作者 邢进 王吉 冯育芳 李晓波 付瑞 肖镜 《实验动物科学》 2024年第2期22-27,共6页
目的分析我国实验动物质量检测能力现状,探讨实验动物质量检测能力验证组织实施现状,研究影响能力验证满意率的关键因素。方法通过Excel2010和Powerpoint2010软件进行实验室数量、项次、满意率以及频次的变化分析。结果2013—2021年共实... 目的分析我国实验动物质量检测能力现状,探讨实验动物质量检测能力验证组织实施现状,研究影响能力验证满意率的关键因素。方法通过Excel2010和Powerpoint2010软件进行实验室数量、项次、满意率以及频次的变化分析。结果2013—2021年共实施27个能力验证计划,包括22种检测能力参数,发放92种生物样本。共有70家实验室参加552个项次,整体满意率达到90.22%。结论持续参加能力验证活动可以提升实验室的检测能力。 展开更多
关键词 能力验证 实验动物 实验室质量控制
下载PDF
大鼠脓毒症肺损伤与中性粒细胞载脂蛋白的相关性研究
15
作者 郑军 祝木建 +3 位作者 李江东 余涵聪 施明栋 李林 《中国感染控制杂志》 CAS CSCD 北大核心 2024年第11期1344-1349,共6页
目的探究大鼠脓毒症肺损伤与中性粒细胞载脂蛋白(HNL)的相关性。方法45只大鼠按照随机方法分为对照组、sham组及模型组,模型组建立脓毒症肺损伤大鼠模型,sham组开腹后仅游离盲肠后关腹,不进行结扎和穿刺,对照组为健康大鼠。使用试剂盒... 目的探究大鼠脓毒症肺损伤与中性粒细胞载脂蛋白(HNL)的相关性。方法45只大鼠按照随机方法分为对照组、sham组及模型组,模型组建立脓毒症肺损伤大鼠模型,sham组开腹后仅游离盲肠后关腹,不进行结扎和穿刺,对照组为健康大鼠。使用试剂盒检测各组大鼠血清白细胞介素(IL)-6、IL-1β、肿瘤坏死因子-α(TNF-α)及HNL;血气分析仪检测氧合指数;计算肺组织湿/干比;HE染色观察肺组织病理形态,计算肺损伤评分。结果对照组及sham组12、24、36 h的IL-6、IL-1β、TNF-α、HNL水平、氧合指数、肺组织湿/干比、肺损伤评分比较,差异均无统计学意义(均P>0.05);与sham组相比,模型组12、24、36 h的IL-6、IL-1β、TNF-α、HNL水平、氧合指数、肺组织湿/干比、肺损伤评分均升高,差异均有统计学意义(均P<0.05)。对照组大鼠12、24、36 h肺组织结构正常,且未见水肿,sham组大鼠12、24、36 h肺组织仅有少量炎症细胞,模型组大鼠12、24、36 h肺组织结构严重破坏,肺泡萎陷,炎症细胞严重浸润,但随着时间延长病理改善。脓毒症肺损伤大鼠中,HNL与IL-6、IL-1β、TNF-α、肺部湿/干比、肺损伤评分呈现正相关性(均P<0.05),与氧合指数呈现负相关性(P<0.05)。结论脓毒症肺损伤大鼠中HNL显著升高,炎症反应严重,肺组织湿/干比、肺损伤加重,氧合指数降低,且HNL水平与IL-6、IL-1β、TNF-α水平、肺组织湿/干比、肺损伤呈正相关性,与氧合指数呈负相关性。 展开更多
关键词 脓毒症 肺损伤 中性粒细胞载脂蛋白 炎症因子 氧合指数 病理形态 动物试验 大鼠
下载PDF
头颈部恶性肿瘤研究模型的演化 被引量:1
16
作者 王安训 周万航 曹琮沅 《口腔疾病防治》 2024年第9期653-663,共11页
恶性肿瘤发生发展的机制探索以及抗癌药物治疗疗效的评估均有赖于各种体内与体外研究模型的建立。近几十年间,随着生物医学技术的快速发展,恶性肿瘤的体内外研究模型也发生了巨大的变化。基因检测技术从单基因到多基因的进展促进了生物... 恶性肿瘤发生发展的机制探索以及抗癌药物治疗疗效的评估均有赖于各种体内与体外研究模型的建立。近几十年间,随着生物医学技术的快速发展,恶性肿瘤的体内外研究模型也发生了巨大的变化。基因检测技术从单基因到多基因的进展促进了生物信息学飞速发展和恶性肿瘤概念的转变;体外细胞研究模型从单层的二维培养、原代培养向立体的三维构型发展,从而更好地重现肿瘤组织的细胞间交互作用与功能;体内动物研究模型由传统的致癌物诱导、细胞或组织形成移植瘤逐渐演变为基因编辑的动物模型或人源性肿瘤异种移植模型,从而可以针对性地研究相关基因在肿瘤发生发展中的作用;传统的临床研究也从简单的临床回顾性研究更多地向前瞻性研究转变,Ⅰ期/Ⅱ期/Ⅲ期临床研究,研究者发起的临床研究以及真实世界临床研究,这些研究为临床研究增添了活力。目前恶性肿瘤研究模型存在的主要不足包括模型的单一性、对肿瘤微环境的模拟不足、动物肿瘤模型与人类肿瘤差异性,以及缺乏对个性化医疗的考量。未来仍需要进一步研发和优化研究模型,并更有效地将不同模型整合起来,形成一个优化的整体实验模型系统。本文将系统回顾恶性肿瘤研究模型的演化并对相关模型进行阐述,为科研工作者进行恶性肿瘤的研究提供合理的研究模型。 展开更多
关键词 恶性肿瘤 研究模型 3D培养技术 肿瘤类器官培养 动物模型 人源肿瘤细胞系异种移植瘤 人源性肿瘤异种移植模型 基因检测 生物信息学 数字肿瘤学 智能肿瘤学
下载PDF
新型鹅细小病毒徐州分离株NGPV XZ-01的分离和致病性研究
17
作者 迟兰 蔺辉星 《畜牧与兽医》 CAS 北大核心 2024年第2期82-88,共7页
为了研究2021年6月江苏徐州某商品半番鸭养殖场所发疾病的病原及其致病性,从该养殖场发病的半番鸭群中无菌采集肝脏、脾脏、肠道等临床样品,采用PCR方法对病原进行鉴定,将所采集样本处理后接种至非免疫鸭胚中,连续多次传代后,对鸭胚组... 为了研究2021年6月江苏徐州某商品半番鸭养殖场所发疾病的病原及其致病性,从该养殖场发病的半番鸭群中无菌采集肝脏、脾脏、肠道等临床样品,采用PCR方法对病原进行鉴定,将所采集样本处理后接种至非免疫鸭胚中,连续多次传代后,对鸭胚组织及尿囊液进行病理学、电镜检查及动物试验。结果显示:PCR检测结果鉴定为新型鹅细小病毒阳性;鸭胚尿囊液在电镜下观察到细小病毒粒子,胚体病理切片观察显示符合细小病毒所致病变;动物试验显示,攻毒试验鸭主要表现为生长发育明显受阻,大部分试验鸭成为“僵鸭”,于20日龄后陆续出现上下喙变短、舌头外露等症状,剖检病变主要为肠内容物稀薄及泄殖腔膨大,肠道组织切片观察显示肠绒毛上皮细胞坏死、脱落及部分肠腺坏死,符合鸭短喙侏儒综合征(short beak and dwarfism syndrome,SBDS)所致雏鸭的症状与病变。结果表明:该肉鸭养殖场所发疾病为SBDS,将该场分离的病毒命名为新型鹅细小病毒徐州分离株(NGPV XZ-01株)。 展开更多
关键词 鸭短喙侏儒综合征 新型鹅细小病毒 徐州分离株 分离鉴定 动物试验
下载PDF
建立我国自主知识产权的致癌性小鼠模型
18
作者 刘甦苏 凌晨 +2 位作者 耿兴超 王三龙 范昌发 《中国食品药品监管》 2024年第6期16-31,共16页
致癌性试验是药物非临床安全性评价的重要内容之一。当前国内外普遍采用并认可基于ICH S1B指南建立的药物非临床致癌性试验替代方案。遗传修饰致癌性小鼠模型是替代方案中“卡脖子”的关键技术问题。从1997年ICH S1B指南发布至今,我国... 致癌性试验是药物非临床安全性评价的重要内容之一。当前国内外普遍采用并认可基于ICH S1B指南建立的药物非临床致癌性试验替代方案。遗传修饰致癌性小鼠模型是替代方案中“卡脖子”的关键技术问题。从1997年ICH S1B指南发布至今,我国制药行业主要依赖进口获得小鼠模型,其价格高昂、进口周期长、条件严苛,且由于模型资源唯一,制药行业承受着成本高昂和供应链不稳的双重压力。本文概述了国内外致癌性试验相关指导原则,介绍了国内外主要的致癌性小鼠模型,包括Tg.rasH2、KI.C57-ras、p53^(+/-)小鼠等的构建、验证与应用历程,并展望了建立我国自主知识产权的致癌性小鼠模型以及标准化生产供应的途径。 展开更多
关键词 药物致癌性试验 致癌性小鼠模型 指导原则 遗传修饰动物模型
下载PDF
EPR长效注射液对靶动物肉牛的安全性试验
19
作者 葛闻博 刘希望 +7 位作者 杨亚军 白莉霞 秦哲 许笑 李准 李欣 李世宏 李剑勇 《中国草食动物科学》 CAS 北大核心 2024年第6期56-62,共7页
试验旨在评价乙酰氨基阿维菌素(Eprinomectin,EPR)长效注射液的安全性,考察安全剂量范围,为临床安全使用提供依据。选用16头健康杂交肉牛,随机分为4组,每组4头(公母各半),分别以推荐剂量(1.0 mg/kg·BW)的0(空白对照组)、1、3、5倍... 试验旨在评价乙酰氨基阿维菌素(Eprinomectin,EPR)长效注射液的安全性,考察安全剂量范围,为临床安全使用提供依据。选用16头健康杂交肉牛,随机分为4组,每组4头(公母各半),分别以推荐剂量(1.0 mg/kg·BW)的0(空白对照组)、1、3、5倍剂量颈部皮下给药1次,给药后观察120 d。观察受试肉牛在试验期间(给药前7天~给药后第120天)的临床表现(精神、行为状况等)、采食、给药局部部位、粪便等,对体温、脉搏、呼吸、采食量、体重等指标进行测量;在给药前一天和给药后(第3天、第28天、第56天、第84天、第112天)采集受试肉牛的尾静脉血,进行血液学和血液生化检查;于给药后第3天和第120天,分别对5倍剂量组和空白对照组试验肉牛各2头(1公1母)进行安乐死,剖检观察心、肝、脾、肺、肾等有无病理变化,计算脏器指数,对主要器官进行组织病理学检查。结果显示,EPR长效注射液对靶动物肉牛的临床表现、粪便和饮食无明显影响,各剂量给药组受试肉牛的体温、脉搏、呼吸频次、体重与空白对照组无显著差异(P>0.05);血液学检查及血液生化分析结果显示,各剂量组试验肉牛指标与空白组均无显著差异(P>0.05);剖检结果显示,5倍剂量组和空白对照组试验肉牛的主要脏器心、肝、脾、肺、肾无肉眼可见的损伤和病变,脏器系数与空白对照组无显著差异(P>0.05);病理组织学检查结果显示,5倍剂量组和空白对照组试验肉牛的主要脏器心、肝、脾、肺、肾无明显的病理变化。综上所述,EPR长效注射液对靶动物肉牛皮下注射给药,即使按5倍推荐剂量单次给药,也无明显的毒副作用和不良反应。因此,EPR长效注射液在靶动物肉牛上按1.0 mg/kg·BW皮下注射给药是安全的。 展开更多
关键词 乙酰氨基阿维菌素 靶动物安全 肉牛 安全性试验
下载PDF
PCR技术在食品检测领域的国内标准使用现状及应用进展 被引量:4
20
作者 白瑞 《工业微生物》 CAS 2024年第2期66-68,91,共4页
PCR技术作为一种高效、快速、高灵敏度和高特异性的检测方法,被广泛应用于食品检测的各个领域中。文章归纳了PCR技术在国内食品检测标准中的应用现状,总结了该技术在食品致病菌检测、转基因食品检测、动物检疫、物种鉴定、过敏原检测及... PCR技术作为一种高效、快速、高灵敏度和高特异性的检测方法,被广泛应用于食品检测的各个领域中。文章归纳了PCR技术在国内食品检测标准中的应用现状,总结了该技术在食品致病菌检测、转基因食品检测、动物检疫、物种鉴定、过敏原检测及食品工业化生产过程中的应用情况,并根据自身的工作经验,指出了PCR技术的发展难点并展望了其发展前景,以期为PCR技术在食品检测领域的广泛应用提供参考和帮助。 展开更多
关键词 PCR 致病菌 动物检疫 转基因食品检测 物种鉴定 过敏原检测
下载PDF
上一页 1 2 46 下一页 到第
使用帮助 返回顶部